--- title: "Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/273753657.md" description: "Charles River Laboratories International Inc. (CRL) shares rose 1.25% to $222.35 on a strong trading day, outperforming competitors like Labcorp Holdings Inc. and Alnylam Pharmaceuticals Inc. The S&P 500 Index increased by 0.50%, while the Dow Jones Industrial Average rose by 0.64%. CRL's stock is currently 2.85% below its 52-week high of $228.88. Trading volume was below the 50-day average, with 440,973 shares traded." datetime: "2026-01-26T22:17:48.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273753657.md) - [en](https://longbridge.com/en/news/273753657.md) - [zh-HK](https://longbridge.com/zh-HK/news/273753657.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273753657.md) | [English](https://longbridge.com/en/news/273753657.md) # Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Charles River Laboratories International Inc. (CRL) advanced 1.25% to $222.35 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.50% to 6,950.23 and the Dow Jones Industrial Average rising 0.64% to 49,412.40. The stock's rise snapped a two-day losing streak. Charles River Laboratories International Inc. closed 2.85% below its 52-week high of $228.88, which the company reached on January 13th. The stock outperformed some of its competitors Monday, as Labcorp Holdings Inc. (LH) rose 0.27% to $267.38, Alnylam Pharmaceuticals Inc. (ALNY) rose 0.94% to $361.35, and Bio-Techne Corp. (TECH) fell 0.78% to $67.63. Trading volume (440,973) remained 342,833 below its 50-day average volume of 783,806. Data source: Dow Jones Market Data, FactSet. Data compiled January 26, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 01-26-26 1717ET ### 相關股票 - [ProShares Ultra Dow30 ETF (DDM.US)](https://longbridge.com/zh-HK/quote/DDM.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [Pro UltrPro Dow30 (UDOW.US)](https://longbridge.com/zh-HK/quote/UDOW.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU.US)](https://longbridge.com/zh-HK/quote/TBXU.US.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md) - [Guggenheim DJIA Ave Div (DJD.US)](https://longbridge.com/zh-HK/quote/DJD.US.md) - [iShares Genomics Immunology and Healthcare ETF (IDNA.US)](https://longbridge.com/zh-HK/quote/IDNA.US.md) - [Ps S&P Low Vol (SPLV.US)](https://longbridge.com/zh-HK/quote/SPLV.US.md) - [Charles River Laboratorie (CRL.US)](https://longbridge.com/zh-HK/quote/CRL.US.md) - [Dow Jones Industrial Average (.DJI.US)](https://longbridge.com/zh-HK/quote/.DJI.US.md) - [iShares Core S&P 500 (IVV.US)](https://longbridge.com/zh-HK/quote/IVV.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [Invesco S&P 500 Eq Wgt ETF (RSP.US)](https://longbridge.com/zh-HK/quote/RSP.US.md) - [SPDR S&P 500 (SPY.US)](https://longbridge.com/zh-HK/quote/SPY.US.md) - [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md) - [VG S&P 500 (VOO.US)](https://longbridge.com/zh-HK/quote/VOO.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [iShares Dow Jones US (IYY.US)](https://longbridge.com/zh-HK/quote/IYY.US.md) - [S&P 500 (.SPX.US)](https://longbridge.com/zh-HK/quote/.SPX.US.md) - [SPDR Djia (DIA.US)](https://longbridge.com/zh-HK/quote/DIA.US.md) - [Alnylam Pharma (ALNY.US)](https://longbridge.com/zh-HK/quote/ALNY.US.md) - [Labcorp (LH.US)](https://longbridge.com/zh-HK/quote/LH.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md) - [Dow Jones U.S. Index (.DJUS.US)](https://longbridge.com/zh-HK/quote/.DJUS.US.md) ## 相關資訊與研究 - [Why Is the SPY ETF Up Today, 4/1/2026?](https://longbridge.com/zh-HK/news/281428290.md) - [Should You Really Invest in the Vanguard S&P 500 ETF Right Now? Here's What History Says.](https://longbridge.com/zh-HK/news/281360255.md) - [LIVE MARKETS-Dow in correction: Can Fibonacci support spark a reversal?](https://longbridge.com/zh-HK/news/281026597.md) - [Here's How Much $100 Invested In ProShares UltraPro S&P 500 5 Years Ago Would Be Worth Today](https://longbridge.com/zh-HK/news/281388760.md) - [S&P 500 Earnings Season Preview: Q1 2026](https://longbridge.com/zh-HK/news/281555757.md)